Want to see QDMI full AI Analyst Report?
Top Page
QDM International
(OTC:QDMI)
Select Model
Select Model
Rating:64Neutral
Price Target:
$8.50
▲(6.25% Upside)
Action:Downgraded
Date:08/26/26
The score is supported by strong profitability and a very low-leverage balance sheet, plus a low P/E valuation. It is held back by materially negative TTM cash flow (weak cash conversion despite strong earnings) and bearish technicals, including a negative MACD and price well below long-term moving averages.
Positive Factors
Revenue Growth
Sustained top-line expansion indicates stronger demand for QDMI’s sample-preparation solutions and supports operating scale. Growth in a specialized molecular biology workflow can strengthen customer relationships and expand the installed base over the next several quarters.
Negative Factors
Negative Cash Conversion
Negative operating and free cash flow despite strong TTM net income raises a quality-of-earnings concern. Persistent working-capital requirements or delayed collections could constrain reinvestment and liquidity, making cash conversion an important fundamental risk over coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained top-line expansion indicates stronger demand for QDMI’s sample-preparation solutions and supports operating scale. Growth in a specialized molecular biology workflow can strengthen customer relationships and expand the installed base over the next several quarters.
Read all positive factors
QDM International (QDMI) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$53.20M
Dividend YieldN/A
Average Volume (3M)85.00
Price to Earnings (P/E)6.8
Beta (1Y)0.74
Revenue Growth138.89%
EPS Growth28.39%
CountryUS
Employees9
SectorFinancial
Sector Strength70
IndustryInsurance - Brokers
Share Statistics
EPS (TTM)N/A
Shares Outstanding8,636,186
10 Day Avg. Volume21
30 Day Avg. Volume85
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)36.76
Price to Sales (P/S)28.03
P/FCF Ratio339.80
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
QDM International Business Overview & Revenue Model
Company Description
QDM International Inc. operates as an insurance brokerage firm, primarily serving the Hong Kong market. The company delivers a broad spectrum of insurance solutions, including personal protection plans such as individual life and health coverage. ...
How the Company Makes Money
QDMI primarily makes money by selling and supporting its sample-preparation solutions used in molecular biology and molecular diagnostics workflows. Key revenue streams typically include: (1) sales of automated DNA extraction instruments and relat...
QDM International Financial Statement Overview
Summary
Income Statement
86
Very Positive
Balance Sheet
90
Very Positive
Cash Flow
55
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.27M | 21.48M | 8.38M | 6.37M | 1.13M | 68.97K |
| Gross Profit | 12.82M | 11.51M | 7.32M | 2.45M | 416.39K | 133.00 |
| EBITDA | 10.38M | 9.15M | 5.96M | 1.91M | 53.82K | -376.50K |
| Net Income | 8.49M | 7.53M | 4.82M | 1.56M | 44.55K | -378.17K |
Balance Sheet | ||||||
| Total Assets | 21.13M | 17.44M | 10.71M | 5.78M | 3.15M | 270.64K |
| Cash, Cash Equivalents and Short-Term Investments | 10.16M | 10.33M | 8.56M | 5.16M | 2.72M | 69.66K |
| Total Debt | 266.06K | 71.38K | 186.51K | 199.28K | 73.80K | 111.35K |
| Total Liabilities | 1.60M | 1.07M | 1.87M | 2.36M | 1.34M | 944.62K |
| Stockholders Equity | 19.53M | 16.37M | 8.84M | 3.42M | 1.81M | -673.97K |
Cash Flow | ||||||
| Free Cash Flow | -2.01M | 1.77M | 4.08M | 2.12M | -5.69K | -402.31K |
| Operating Cash Flow | -2.01M | 1.77M | 4.08M | 2.21M | 11.81K | -398.61K |
| Investing Cash Flow | -282.05K | 0.00 | 0.00 | -100.00K | -17.50K | -3.70K |
| Financing Cash Flow | 40.00K | 0.00 | -683.22K | 332.89K | 2.65M | 436.36K |
QDM International Risk Analysis
QDM International disclosed 44 risk factors in its most recent earnings report. QDM International reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
QDM International Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | $17.79M | 1.42 | 0.99% | ― | ― | ― | |
65 Neutral | $597.80M | 27.23 | 13.01% | 2.73% | -4.12% | -20.24% | |
64 Neutral | $53.20M | 6.83 | 87.97% | ― | 138.89% | 28.39% | |
59 Neutral | $38.12M | -1.37 | 3.23% | ― | -8.37% | -220.33% | |
59 Neutral | $97.12M | -7.71 | 10.03% | ― | 6.02% | -144.93% | |
56 Neutral | $597.80M | 27.23 | 13.01% | 2.97% | -4.12% | -20.24% |
* Financial Sector Average
QDMI
QDM International
6.69
-61.31
-90.16%
CRD.A
Crawford & Company A
13.07
2.51
23.75%
EHTH
Ehealth
1.14
-2.75
-70.69%
CRD.B
Crawford & Company B
11.80
1.55
15.08%
HUIZ
Huize Holding
1.71
-0.75
-30.49%
SLQT
SelectQuote
0.54
-1.72
-76.11%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.